|
|
|
|
|
|
|
|
|
Webinar: Autonomous Impinging Jet Mixing for LNP Process Development
|
Lipid nanoparticle (LNP) development can be slow and resource-intensive. Discover how impinging jet mixing, automation, inline analytics, and data-driven optimization can accelerate process development and enable more predictive manufacturing. This Knauer webinar will explore closed-loop experimentation, automated design of experiments, self-optimization, and modeling approaches that can help identify robust conditions faster and support scalable, reproducible LNP production. Click here to learn more.
|
|
|
|
|
|
|
|
By Anna Rose Welch, Advancing RNA
|
Of course, these conversations are rarely simple, and the learnings are multifaceted. In this three-part series, I’ll share my 3 biggest takeaways from the discussion between Coller, Ahrens-Nicklas, and Strauss. Here in part 1, I’ll start by parsing out the learnings about drug development we can take away from the overall heroic efforts to dose Baby KJ.
|
|
|
|
|
|
Building A Self-Driving Lab For LNP Development
|
|
A conversation with Peter Sagmeister and Aniket Udepurkar, and Life Science Connect's Jon O'Connell
|
With commercially available components, MIT researchers built a platform that accelerates LNP process development, optimization, and autonomous manufacturing research.
|
|
|
|
Beyond Vaccines: Can RNA Sense Gases?
|
|
By Savani Anbalagan, Ph.D., Adam Mickiewicz University, Poznan, Poland
|
Could RNA sense its environment? A new hypothesis explores how RNA may detect temperature and gases, inspiring smarter, adaptive RNA therapeutics.
|
|
|
|
|
|
|
|
|
|
Next Generation Sequencing In Viral Safety Testing
|
|
White Paper | By Victor Muthu, Ph.D., Eurofins
|
Next Generation Sequencing offers a sensitive, high-throughput model to detect adventitious viral agents, enhancing safety and streamlining regulatory-compliant product workflows.
|
|
|
|
|
|
Large Scale Purification Of Oligonucleotides With IEX
|
|
Application Note | KNAUER
|
As oligonucleotide-based drugs gain momentum in therapeutic development, refining their manufacturing processes through solutions like ion exchange chromatography (IEX) becomes crucial.
|
|
|
|
|
|
Unmatched Beginnings That Shape Late-Phase Success
|
|
E-Book | Aldevron
|
Early research choices shape outcomes. Focusing on reproducibility, scalability, regulatory fit, and supply stability early cuts risk, prevents delays, and supports smoother development progress.
|
|
|
|
|
|
Mapping The Value Landscape Of mRNA Therapeutics
|
|
White Paper | By Scott Alderucci, Curia
|
Discover how decades of research have propelled mRNA technology to the forefront of therapeutic development and learn how expertise is advancing mRNA drug development.
|
|
|
|
|
|
|
|
|
|
|
|
Cell 2026 | 12-13 November, London, UK
|
Advanced therapy development moves fast, and the companies shaping it are the ones connecting science, scale and strategy in the same room. Cell 2026 is where that happens. Partner with us to reach 800+ senior pharma, biotech and R&D decision-makers through guaranteed 1:1 meetings, speaking slots, roundtables and tailored digital campaigns. Get in touch and we'll design a package around your objectives.
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
